Dr. Susan Tannenbaum, MD
Claim this profileUniversity of Connecticut Medical Center
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
2 reported clinical trials
3 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage IV
Stage III
2Lung Cancer
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Susan Tannenbaum, MD is currently running
ONC-392 vs Chemotherapy
for Lung Cancer
This trial is testing gotistobart, a new drug that helps the immune system fight advanced lung cancer in patients who haven't responded to other treatments. It works by blocking a protein that allows cancer cells to hide from the immune system.
Recruiting2 awards Phase 310 criteria
ONC-392 + Pembrolizumab
for Non-Small Cell Lung Cancer
This trial tests ONC-392, an antibody that helps the immune system fight cancer, in patients with advanced or spreading tumors who haven't responded to other treatments. It works by blocking a protein that usually keeps immune responses in check, making it easier for the body to attack cancer cells.
Recruiting1 award Phase 1 & 212 criteria
More about Susan Tannenbaum, MD
Clinical Trial Related1 year of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Susan Tannenbaum, MD has experience with
- ONC-392
- Pembrolizumab
- Docetaxel
Breakdown of trials Susan Tannenbaum, MD has run
Non-Small Cell Lung Cancer
Lung Cancer
Colorectal Cancer
Ovarian Cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Susan Tannenbaum, MD specialize in?
Susan Tannenbaum, MD focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Susan Tannenbaum, MD currently recruiting for clinical trials?
Yes, Susan Tannenbaum, MD is currently recruiting for 2 clinical trials in Farmington Connecticut. If you're interested in participating, you should apply.
Are there any treatments that Susan Tannenbaum, MD has studied deeply?
Yes, Susan Tannenbaum, MD has studied treatments such as ONC-392, Pembrolizumab, Docetaxel.
What is the best way to schedule an appointment with Susan Tannenbaum, MD?
Apply for one of the trials that Susan Tannenbaum, MD is conducting.
What is the office address of Susan Tannenbaum, MD?
The office of Susan Tannenbaum, MD is located at: University of Connecticut Medical Center, Farmington, Connecticut 06030 United States. This is the address for their practice at the University of Connecticut Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.